1. Home
  2. RBC vs MEDP Comparison

RBC vs MEDP Comparison

Compare RBC & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBC
  • MEDP
  • Stock Information
  • Founded
  • RBC 1919
  • MEDP 1992
  • Country
  • RBC United States
  • MEDP United States
  • Employees
  • RBC N/A
  • MEDP N/A
  • Industry
  • RBC Metal Fabrications
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • RBC Industrials
  • MEDP Health Care
  • Exchange
  • RBC Nasdaq
  • MEDP Nasdaq
  • Market Cap
  • RBC 12.6B
  • MEDP 13.4B
  • IPO Year
  • RBC 2005
  • MEDP 2016
  • Fundamental
  • Price
  • RBC $440.58
  • MEDP $602.14
  • Analyst Decision
  • RBC Buy
  • MEDP Hold
  • Analyst Count
  • RBC 6
  • MEDP 11
  • Target Price
  • RBC $441.17
  • MEDP $451.70
  • AVG Volume (30 Days)
  • RBC 246.3K
  • MEDP 339.4K
  • Earning Date
  • RBC 10-31-2025
  • MEDP 10-22-2025
  • Dividend Yield
  • RBC N/A
  • MEDP N/A
  • EPS Growth
  • RBC 19.54
  • MEDP 25.36
  • EPS
  • RBC 8.20
  • MEDP 14.32
  • Revenue
  • RBC $1,723,400,000.00
  • MEDP $2,358,373,000.00
  • Revenue This Year
  • RBC $14.28
  • MEDP $21.48
  • Revenue Next Year
  • RBC $10.86
  • MEDP $11.90
  • P/E Ratio
  • RBC $53.88
  • MEDP $41.92
  • Revenue Growth
  • RBC 8.27
  • MEDP 13.88
  • 52 Week Low
  • RBC $290.56
  • MEDP $250.05
  • 52 Week High
  • RBC $442.14
  • MEDP $625.00
  • Technical
  • Relative Strength Index (RSI)
  • RBC 75.47
  • MEDP 67.42
  • Support Level
  • RBC $422.62
  • MEDP $573.07
  • Resistance Level
  • RBC $439.10
  • MEDP $602.54
  • Average True Range (ATR)
  • RBC 11.26
  • MEDP 20.92
  • MACD
  • RBC 3.28
  • MEDP -0.56
  • Stochastic Oscillator
  • RBC 96.12
  • MEDP 75.02

About RBC RBC Bearings Incorporated

RBC Bearings Inc is an international manufacturer and marketer of engineered precision bearings, components, and essential systems for the industrial, defense, and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The company has two reportable segments: Industrial, which derives maximum revenue, and Aerospace/Defense. The Aerospace/Defense segment represents the end markets for the company's engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and the Industrial segment represents the end markets for its products used in various industrial applications. Geographically, the company generates a majority of its revenue from the United States.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: